← Evidence map

ArticleAllergy and asthma proceedings2023

The COVID-19 impact on severe uncontrolled asthma costs and biologic use.

Najm S Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37641228